These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 32103065)

  • 41. Self-renewal gene tracking to identify tumour-initiating cells associated with metastatic potential.
    Darini CY; Pisani DF; Hofman P; Pedeutour F; Sudaka I; Chomienne C; Dani C; Ladoux A
    Oncogene; 2012 May; 31(19):2438-49. PubMed ID: 21927026
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Reprogramming of retinoblastoma cancer cells into cancer stem cells.
    Yue F; Hirashima K; Tomotsune D; Takizawa-Shirasawa S; Yokoyama T; Sasaki K
    Biochem Biophys Res Commun; 2017 Jan; 482(4):549-555. PubMed ID: 27856246
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Discovery of a novel unfolded protein response phenotype of cancer stem/progenitor cells from the bone marrow of breast cancer patients.
    Bartkowiak K; Effenberger KE; Harder S; Andreas A; Buck F; Peter-Katalinic J; Pantel K; Brandt BH
    J Proteome Res; 2010 Jun; 9(6):3158-68. PubMed ID: 20423148
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CD44 and CD24 coordinate the reprogramming of nasopharyngeal carcinoma cells towards a cancer stem cell phenotype through STAT3 activation.
    Shen YA; Wang CY; Chuang HY; Hwang JJ; Chi WH; Shu CH; Ho CY; Li WY; Chen YJ
    Oncotarget; 2016 Sep; 7(36):58351-58366. PubMed ID: 27521216
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A CD44v
    Hu J; Li G; Zhang P; Zhuang X; Hu G
    Cell Death Dis; 2017 Mar; 8(3):e2679. PubMed ID: 28300837
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Screening of Human cDNA Library Reveals Two differentiation-Related Genes, HHEX and HLX, as Promoters of Early Phase Reprogramming toward Pluripotency.
    Yamakawa T; Sato Y; Matsumura Y; Kobayashi Y; Kawamura Y; Goshima N; Yamanaka S; Okita K
    Stem Cells; 2016 Nov; 34(11):2661-2669. PubMed ID: 27335261
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Smoothened activates breast cancer stem-like cell and promotes tumorigenesis and metastasis of breast cancer.
    Wang L; Duan W; Kang L; Mao J; Yu X; Fan S; Li L; Tao Y
    Biomed Pharmacother; 2014 Oct; 68(8):1099-104. PubMed ID: 25451166
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cervical Cancer Stem Cells Selectively Overexpress HPV Oncoprotein E6 that Controls Stemness and Self-Renewal through Upregulation of HES1.
    Tyagi A; Vishnoi K; Mahata S; Verma G; Srivastava Y; Masaldan S; Roy BG; Bharti AC; Das BC
    Clin Cancer Res; 2016 Aug; 22(16):4170-84. PubMed ID: 26988248
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Engagement of cellular prion protein with the co-chaperone Hsp70/90 organizing protein regulates the proliferation of glioblastoma stem-like cells.
    Iglesia RP; Prado MB; Cruz L; Martins VR; Santos TG; Lopes MH
    Stem Cell Res Ther; 2017 Apr; 8(1):76. PubMed ID: 28412969
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The COOH-Terminal Proline-Rich Region of GRP78 Is a Key Regulator of Its Cell Surface Expression and Viability of Tamoxifen-Resistant Breast Cancer Cells.
    Tseng CC; Zhang P; Lee AS
    Neoplasia; 2019 Aug; 21(8):837-848. PubMed ID: 31306849
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fascin Is Critical for the Maintenance of Breast Cancer Stem Cell Pool Predominantly via the Activation of the Notch Self-Renewal Pathway.
    Barnawi R; Al-Khaldi S; Majed Sleiman G; Sarkar A; Al-Dhfyan A; Al-Mohanna F; Ghebeh H; Al-Alwan M
    Stem Cells; 2016 Dec; 34(12):2799-2813. PubMed ID: 27502039
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Colon adenocarcinoma-derived cells that express induced-pluripotent stem cell markers possess stem cell function.
    Munro MJ; Peng L; Wickremesekera SK; Tan ST
    PLoS One; 2020; 15(5):e0232934. PubMed ID: 32428045
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Plumbagin sensitizes breast cancer cells to tamoxifen-induced cell death through GRP78 inhibition and Bik upregulation.
    Kawiak A; Domachowska A; Jaworska A; Lojkowska E
    Sci Rep; 2017 Mar; 7():43781. PubMed ID: 28287102
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Targeted Therapy for Breast Cancer Stem Cells by Liposomal Delivery of siRNA against Fibronectin EDB.
    Sun Y; Kim HS; Saw PE; Jon S; Moon WK
    Adv Healthc Mater; 2015 Aug; 4(11):1675-80. PubMed ID: 26097122
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long non-coding RNA LUCAT1/miR-5582-3p/TCF7L2 axis regulates breast cancer stemness via Wnt/β-catenin pathway.
    Zheng A; Song X; Zhang L; Zhao L; Mao X; Wei M; Jin F
    J Exp Clin Cancer Res; 2019 Jul; 38(1):305. PubMed ID: 31300015
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Plasticity between Epithelial and Mesenchymal States Unlinks EMT from Metastasis-Enhancing Stem Cell Capacity.
    Beerling E; Seinstra D; de Wit E; Kester L; van der Velden D; Maynard C; Schäfer R; van Diest P; Voest E; van Oudenaarden A; Vrisekoop N; van Rheenen J
    Cell Rep; 2016 Mar; 14(10):2281-8. PubMed ID: 26947068
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibition of KLF4 by Statins Reverses Adriamycin-Induced Metastasis and Cancer Stemness in Osteosarcoma Cells.
    Li Y; Xian M; Yang B; Ying M; He Q
    Stem Cell Reports; 2017 Jun; 8(6):1617-1629. PubMed ID: 28552603
    [TBL] [Abstract][Full Text] [Related]  

  • 58. IGFBP-3 binds GRP78, stimulates autophagy and promotes the survival of breast cancer cells exposed to adverse microenvironments.
    Grkovic S; O'Reilly VC; Han S; Hong M; Baxter RC; Firth SM
    Oncogene; 2013 May; 32(19):2412-20. PubMed ID: 22751133
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Requirement of the transcription factor YB-1 for maintaining the stemness of cancer stem cells and reverting differentiated cancer cells into cancer stem cells.
    Yang F; Cui P; Lu Y; Zhang X
    Stem Cell Res Ther; 2019 Aug; 10(1):233. PubMed ID: 31375149
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Silencing PRDM14 expression by an innovative RNAi therapy inhibits stemness, tumorigenicity, and metastasis of breast cancer.
    Taniguchi H; Hoshino D; Moriya C; Zembutsu H; Nishiyama N; Yamamoto H; Kataoka K; Imai K
    Oncotarget; 2017 Jul; 8(29):46856-46874. PubMed ID: 28423353
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.